WASHINGTON--(BUSINESS WIRE)--Drug eluting balloons could offer a viable alternative to drug eluting stents (DES) in the treatment of coronary artery disease. Research results from two studies presented today at the Late Breaking Trials sessions during the Cardiovascular Research Foundation’s (CRF) Nineteenth Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Washington, D.C. support conducting further studies of the use of this potential therapeutic alternative. One of the studies marked the first direct comparison between DES and drug eluting balloons.
